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The vegetation of Northeastern Brazil is an important source of income for the local population. 
Poincianella pyramidalis is a very important species in the semiarid and is inserted in various 
categories of ethnobotanical use, as foraging, construction and technology uses. However, the most 
important use is medicinal. Several preparations obtained from the root, bark, leaves and flowers of P. 
pyramidalis are used to treat various ailments, especially infections, pain and inflammation. This paper 
discusses the medical use, chemical constituents and pharmacological potential of P. pyramidalis. This 
revision was based on studies published in scientific journals, books, and search sites such as Science 
Direct, PubMed and American Chemical Society (ACS). P. pyramidalis features a wealth of secondary 
metabolites, belonging to the most diverse classes as flavonoids, terpenoids, tannins and others. Of 
these, 22 compounds were included in this review. The species showed significant ability to perform 
biological activities such as antimicrobial, anti-inflammatory, gastroprotective, radioprotective and 
anticancer, as well as being both a molluscicide and larvicide. On the other hand, the species showed 
relative toxicity. Numerous compounds in P. pyramidalis were identified with recognized action on the 
body, where anti-inflammatory and antimicrobial activities were the most pronounced. All parts of the 
plant stem, flower, root and leaf showed pharmacological action validating many traditional uses. 
However, the identification of the chemical constituents or group responsible for producing these 
therapeutic actions, as well as carrying out of further test in vivo to determine the mechanisms of 
action related to biological activities is required. 
 













catingueira, pau-de-rato or catinga-de-porco. Until 
recently, this species was known as Caesalpinia 
pyramidalis Tul., and, as a result of a taxonomic 
reformulation, it belongs to the genus Poincianella 
(Queiroz, 2009). P. pyramidalis is a small unarmed tree 
that can reach 4 m and greater heights in certain 
environments. It has bipinnate leaves with 5 to 11 leaflets 
that are sessile, alternate, leathery, oblong and obtuse. It 
has yellow flowers arranged in racemes with similar 
length to the leaves. The fruit is a pod that is sessile, 
leathery, flat, dark in color and can be up to 11 cm long 
(Corrêa, 1926; Braga, 1960). This species is a native 
pioneer and endemic of the Caatinga, broadly distributed 
in Northeastern Brazil, occurring in the states of Piauí, 
Ceará, Rio Grande do Norte, Paraíba, Pernambuco, 
Alagoas, Sergipe and Bahia (Valladares et al., 2007; 
Santana et al., 2011). It adapts to xeric and degraded 
environments and can be found in several plant 
associations, inhabiting stony ground and growing well in 
humid lowlands (Lima, 1996; Oliveira, 2010). These 
features ensure its successful cultivation throughout the 
Brazilian semiarid climate (Fabricante et al., 2009). 
P. pyramidalis is considered as one of the most useful 
species for the people of that area because of its 
multiplicity of uses (Lucena et al., 2012). Among these 
uses is that of folk medicine, in which its flowers, leaves, 
and barks are used primarily in the treatment of infectious 
diseases and as an anti-inflammatory and analgesic 
(Braga, 1960; Maia, 2004; Santos et al., 2008). Its 
popular medicinal uses have attracted the attention of 
researchers from different areas. In recent years, studies 
have been developed to evaluate the chemical 
composition and biological activities of P. pyramidalis, 
including its antimicrobial, antioxidant, gastroprotective, 
anti-inflammatory, antinociceptive, radioprotective, and 
anthelmintic properties, apart from toxicity. This review 
aims to highlight the traditional medicinal use and main 
biological and phytochemical properties of P. pyramidalis, 





P. pyramidalis is a perpetual contributor to the various 
health problems of the Brazilian semiarid population. The 
uses of the stem bark, leaves, flowers and roots of this 





The presence of diterpenes, flavonoids, and other 
phenolic compounds is  characteristic  of  this  genre  and  
 




family. Lignans, gallic acid, steroids, phenylpropanoid, 
and tannins, flavonoids and especially biflavonoids are 
isolated in the leaves and stem of P. pyramidalis 
(Mendes et al., 2000; Bahia et al., 2005; Bahia et al., 
2010; Oliveira, 2010). Monteiro (2005) quantified the 
greater abundance of metabolites in the methanol extract 
from the bark of catingueira, where he obtained 29.60 
and 24.72 mg for total phenol and tannins, respectively. 
The chloroform extract of the leaves provides biflavonoids 
and phenolic compounds called caesalflavona, 
podocarpusflavona A, agathisflavona, apigenin, 
kaempferol, sitosterol and lupeol. Phenylpropanoid 
glycoside acid, 4-Ob-glucopyranosyloxy-7-Z-
hydroxycinnamic acid and 4-Ob-glucopiranosiloxi Z-8-
hydroxycinnamic acid were also isolated from the leaves. 
The chloroform extract gave the stem 4, 4'-dihydroxy-2'-
methoxy-chalcone, (-) - Methyl gallate and syringaresinol 
(Table 2) (Mendes et al., 2000; Bahia et al., 2005; 
Borges-dos-Santos et al., 2012). The hexane phase of 
the root was the isolation of lupeol, acacetina, 
phenylpropanoid, and a mixture of sitosterol and 
stigmasterol. From the methanolic phase one biflavonoid 
was isolated, and also 7-hydroxy-4'-methoxyflavone-5α-
2,4-dihydroxy-4'-metoxidihidrochalcona (Oliveira, 2010). 
The chemical structure of some of these molecules is 
shown in Figure 1. 
 
 




There is a concern in global public health about bacteria 
resistant to most known antibiotics and their prevalence 
in causing morbidity and mortality. Staphylococcus 
aureus is one of the main actors in this scenario, 
commonly occurring in strains resistant to methicillin 
(MRSA), and recently, vancomycin (VRSA). So, with the 
discovery of new antibacterial agents with different 
mechanisms of action, new research is vital (Luna et al., 
2010). Novais et al. (2003) observed a good 
microbiological activity in the ethyl acetate extract 
obtained from the bark and leaves of P. pyramidalis 
against S. aureus, by disk diffusion method. Alviano et al. 
(2008) also noted antibacterial activity against oral 
pathogens in the bark and leaves of this plant. The MIC 
values observed in this study were 1000 µ mL
-1
 to 
Prevotella intermedia, Porphyromonas gingivalis and 
Fusobacterium nucleatum, and 8000 µg mL
-1
 to 
Streptococcus mutans and Lactobacillus casei, 
microorganisms related to dental caries.  
In their study, Saraiva et al. (2012a) evaluated the 
activity  of  the  methanol  extracts,  ethyl acetate  and  n-  
 
 *Corresponding author. E-mail: anaclaudia@uepb.edu.br. Tel/Fax: +55 83 3315 3300 (Ext. 3516).  
 
Author(s) agree that this article remains permanently open access under the terms of the Creative Commons Attribution 
License 4.0 International License 




Table 1. Poincianella pyramidalis uses in traditional medicine. 
 





Respiratory problems: asthma, bronchitis, 
expectorant, flu, respiratory infection, catarrhal 
infections, cough. 
 Gastrointestinal problems: heartburn, colic, 
diarrhea, dysentery, flatulence, gastritis, 
indigestion, stomach pain, stomach problems.  
Problems of the circulatory system: hemostatic,  
Undefined symptoms: inflammation, fever. 
Recreation: Aphrodisiac.  
Lesions: Cicatrizant, injuries, bruises.  
Endocrine problems: Diabetes. 
Lima, 1996; Agra et al., 2007a; 2007b; 
2008; Cartaxo et al., 2010; 
Albuquerque et al, 2007; Albuquerque 
et al., 2006;  Oliveira et al., 2010; 
Marinho et al., 2011; Silva and 
Albuquerque, 2005; Albuquerque and 
Andrade 2002a,b; Albuquerque 2006; 
Silva and Freire, 2010; Silva et al., 
2011b; Pereira Jr et al., 2014; Silva et 
al., 2015; 
    
Flower Infusion, syrup 
Respiratory problems: asthma, bronchitis, 
expectorant, flu, respiratory infection, catarrhal 
infections, cough.  
Gastrointestinal problems: heartburn, colic, 
diarrhea, dysentery, flatulence, gastritis, 
indigestion, stomach pain, stomach problems. 
Problems of the circulatory system: hemostatic, 
Undefined symptoms: fever. Recreation: 
Aphrodisiac. Lesions: Cicatrizant, injuries, bruises. 
Endocrine problems: Diabetes. 
Cartaxo et al., 2010; Lima, 1996; 
Albuquerque et al, 2007; Almeida et 
al., 2006; Souza et al., 2011; Pereira 
Jr et al., 2014. 
    
Leaves Infusion 
Respiratory problems: asthma, bronchitis, 
expectorant, flu, respiratory infection, catarrhal 
infections, cough. 
 Gastrointestinal problems: colic, diarrhea, 
dysentery, flatulence, gastritis, stomach pain, 
indigestion.  
Fungicide: candidiasis.  
Lesions: Cicatrizant, injuries, bruises.  
Endocrine problems: Diabetes.  
Other: Diuretic.  
Almeida et al., 2005, 2006; Bahia et 
al., 2010; Cruz et al., 2007; Lima, 
1996; Albuquerque et al., 2007; 
Ribeiro et al., 2014. 
    
Root Decoction 
Respiratory problems: asthma, bronchitis, 
expectorant, respiratory infection, flu, cough. 
Gastrointestinal problems: heartburn, colic, 
diarrhea, stomach pain, flatulence, gastritis. 
Undefined symptoms: fever.  
Lesions: wounds, bruises.  
Endocrine problems: Diabetes. 




hexane against 17 isolates multiresistant MRSA, 2 MSSA 
and 2 standard strains of S. aureus. A good activity to the 
methanol extracts of the leaves, flowers, bark, roots, 
fruits and seeds, and to the ethyl acetate extract of the 
bark, roots and fruits (MIC ≤ 1000 µg mL
-1
) was 
observed. The antimicrobial efficacy of these extracts 
against Escherichia coli, Enterococcus faecalis, 
Klebsiella pneumoniae, Salmonella spp., S. aureus and 
Pseudomonas aeruginosa (Saraiva et al., 2012b) was 
observed. MIC values of  methanol  extract of  the  leaves 
against P. aeruginosa (MIC = 125 µg ml
-1
), and  the  ethyl 
acetate extract of the root against E. coli and S. aureus 
were 500 and 250 µg ml
-1
, respectively; and the methanol 
extract of the leaves against E. coli was 250 µg ml
-1
. In 
another study, it was found that the ethanolic extracts of 
the leaves of P. pyramidalis against strains of MRSA and 
S. aureus with NorA efflux pump protein overexpression. 
It was observed that the bacterial growth of S. aureus 
resistant NorA was 10-fold less than the negative control 
(DMSO 1%); and there was no observed growth of the 
MRSA strain after 24 h of incubation (Lima et al., 2006). 
P.   pyramidalis    also    presented   significant  antifungal 




Table 2. Chemical constituents of Poincianella pyramidalis. 
 
S/N 
Part of  
plant 
Substance Group References 
1 Leaf, root Lupeol Triterpene 
Mendes et al., 2000. Oliveira, 2010; Bahia et 
al., 2005 
2 Leaf, root Sitosterol Steroid Bahia et al., 2005; Oliveira, 2010 
3 Root Estigmasterol Steroid Oliveira, 2010; Bahia et al., 2010 
4 Root Acacetina Flavonoid Oliveira, 2010; 
5 Root Acid (E)-8-hydroxy-3,5-dimetoxycumaric Phenylpropanoid Oliveira, 2010 
6 Root 7-hydroxy-4’-metoxyflavone-5α-2,4-dihydroxy-4’-metoxydihydrochalcone. Biflavonoid Oliveira, 2010 
7 Leaf Caesalflavone Biflavonoid Bahia et al., 2005 
8 Leaf Podocarpusflavone A Biflavonoid Bahia et al, 2005 
9 Leaf Agathisflavone Biflavonoid 
Bahia et al., 2005; Borges-dos-Santos, 2012; 
Mendes et al., 2000 
10 Leaf Kaempferol Flavonol  Bahia et al., 2005 
11 Leaf Apigenin Flavone Bahia et al., 2005 
12 Leaf 4-O-β-glucopiranosyloxy-Z-7-hydroxycinnamic Fenilpropanoid Mendes et al., 2000 
13 Leaf Acid 4-O-β-D-glucopyranosyloxy-8-Z-hydroxycinnamic Fenilpropanoid Mendes et al., 2000 
14 Root 7-hydroxy-4'-methoxyflavone-5α-2,4-dihydroxy-4'-metoxidihidrochalcone Biflavonoid Oliveira, 2010 
15 Leaf  Amentoflavone   Biflavonoid  Bahia et al., 2010 
16 Leaf  Sequoiaflavone Biflavonoid  Bahia et al., 2010 
17 Stem bark Methyl gallate Phenolic ester Bahia et al., 2005 
18 Stem bark 4, 4'-dihydroxy-2'-methoxy-chalcone Chalcone Bahia et al., 2005 
19 Leaf Taxifolin Flavonone Bahia et al., 2010 
20 Leaf Loniflavone Biflavonoid  Bahia et al., 2010 
21 Leaf   5-hidroxiamentoflavone Biflavonoid  Bahia et al., 2010 




properties. Cruz et al. (2007) evaluated the 
antifungal activity of four Brazilian medicinal 
plants used in folk medicine for the treatment of 
fungal infections. P. pyramidalis presented the 
best results of aqueous extract of the leaves; it 
had significant activity against standard strains 
ATCC and clinical isolates of Trichophyton rubrum 
(MIC = 6.25 μg mL
-1
), Candida guilliermondii (MIC 
= 25 μg mL
-1
), Candida albicans (MIC = 12.5 μg 
mL
-1
), Cryptococcus neoformans (MIC = 12.5 μg 
mL
-1




Barbosa et al. (2015) evaluated the susceptibility 
of clinical isolates of Cryptococcus neoformans 
resistant to azole antifungal and ATCC strain 
using plant extracts obtained from medicinal 
plants in the semiarid region of the State of 
Sergipe, Brazil. The researchers used the disk 
diffusion method and the aqueous extract of 
leaves of P. pyramidalis at a concentration of 4, 40 
and 100 mg mL
-1
. The extracts showed good 
activity against 5 of the 10 strains tested, with 
zones of inhibition ranging between 7 and 14 mm. 
The activity of ethanolic extract of the bark of P. 
pyramidalis against standard ATCC strain of 
Helicobacter pylori evaluated by Ribeiro et al. 
(2013) had 625 and 10,000 μg mL
-1
, of  MIC and 

















The production of free radicals in the body causes 
numerous problems that manifest as degenerative 
diseases, cardiovascular diseases, aging, and immune 
problems; therefore, this creates a need to discover new 
antioxidants. In plants, phenolic substances act as free 
radical scavengers and metal chelators, which may be 
used as antioxidants in various pathologies (Haslam, 
1998). Santos (2010) determined the antioxidant activity 
of ethanolic extract of the bark of P. pyramidalis, by 
method of thiobarbituric acid reactive substances 
(TBARS). This indicates the lipid peroxidation. The 
extract (concentrations of 100 and 1000 µg mL
-1
) showed 
antioxidant activity reducing significantly (P < 0.001) lipid 
peroxidation compared to the control (77.66 and 82.41%, 
respectively). This was achieved by the reduction of 
TBARS production. The antioxidant potential of Brazilian 
medicinal plants was evaluated by Alviano et al. (2008) 
using photometric test DPPH. The aqueous extract of 
leaves of P. pyramidalis presented a great elimination 
activities of DPPH (EC50 = 15.2 ± 1.0 mg L
-1
), and was 
better than the synthetic antioxidant BHT (EC50 = 86 μg 
mL
-1
). While in another study by Silva et al. (2011a), the 
antioxidant activity of ethanolic extract of the bark and 
leaves was evaluated by DPPH and FIC assays. The 
extract from the bark showed high antioxidant activity (IC 
50 = 16.98 ± 1.34 μg mL
-1
) compared to standards rutin 
and ascorbic acid (IC 50 = 22.96 ± 1.99 and 16.12 ± 0 01 
μg mL
-1
, respectively). Moreover, the extract of leaves 
was more effective in chelating ferrous ions (IC50 = 62.49 
± 10.77 μg mL
-1
), with IC50 values closer to EDTA control 
(IC50 = 15.26 ± 0.58 μg mL
-1
). 
Melo et al. (2010) evaluated the antioxidant activity of 
14 medicinal plants of the Brazilian semi-arid region; P. 
pyramidalis presented lower IC50 value (42.95 ± 1.77 μg 
mL
-1
) and good antioxidant activity. The authors attributed 
this to the antioxidant activity, that the high concentration 





Ribeiro et al. (2013) evaluated the antiulcerogenic activity 
and gastric mucosal protection factors of ethanolic extract 
of the bark of P. pyramidalis through several in vivo 
models using Wistar rats. In the ethanol-induced ulcer 
model, the animals were treated with doses of extracts of 
30, 100 and 300 mg kg
-1
, and the results showed 
inhibition of the parameters with higher concentration. 
The values of ulcer lesion index, total lesion area, and 
percentage of lesion to extract were 0.92±0.40, 0.93±0.46 
mm
2
, 0.16±0.08%, respectively. Histopathological analysis  




showed that the animals pretreated with the extract 
showed less mucosal damage compared to the control 
group. In the indomethacin-induced ulcers model, the 
extract (100 mg kg
-1
) and positive control (Cimetidine 100 
mg kg
-1
) significantly reduced the ulcer, exhibiting the 
same ulcer inhibition rate (86.97%). In the model gastric 
secretion, using ligation of pylorus in groups treated with 
the extract of P. pyramidalis, there was a volume of 
discharge and acid secretion was not reduced compared 
to the vehicle. However, when these groups were 
compared to the model determination mucus there was a 
significant increase in mucus production (vehicle = 1.00 ± 
0.13 mg L
-1
; extract 300 mg kg
-1
 = 1.61 ± 0.09 mg L
-1
). 
Diniz et al. (2015) investigated the possible 
mechanisms of the action of ethanolic extract of the bark 
of P. pyramidalis against ethanol-induced gastric damage. 
To evaluate the possible involvement of gaseous 
mediators (nitric oxide and hydrogen sulfide) in the 
protective extract, pretreated groups of rats with L-NAME 
or PAG were used. The protective effect of the extract 
was significantly attenuated by pretreatment with PAG, 
suggesting possible involvement of H2S in the gastro 
protector extract. The authors believe that another 
mechanism of action would be an anti-inflammatory effect 
on gastric mucosa caused by attenuation of expression of 
the inflammatory mediator gene and increased expression 





The anti-inflammatory activity of ethanolic extract (90%) 
of P. pyramidalis was evaluated by in vivo models with 
Wistar rats. In the model of carrageenan-induced edema 
and MPO activity in rat paws, the extract (400 mg Kg
-1
) 
was able to reduce the edema at 2, 3 and 4 h after the 
injection of carrageenan. The group treated with the 
extract has inhibition of edema (41.2%), while 
dexamethasone (2 mg kg
-1
) unleashed an inhibition of 
54.4% compared to the group treated with carrageenan. 
The extract at the same concentration was also able to 
reduce the action of MPO. The group treated with the 
extract showed 4.5 ± 0.5 mg UMPO
-1
 and the vehicle 
group had 7.1 ± 0.9 mg UMPO
-1
. In addition, the activity 
of this extract was against carrageenan-induced peritonitis 
in mice. The extract (400 mg kg
-1
) significantly inhibited 
the migration of leukocytes into the peritoneal cavity (2.63 
± 0.23 × 106 mL
-1
 of leukocytes / 80.2% inhibition) 
compared to the vehicle group (7 22 ± 0.99 × 106 mL
-1
 of 
leukocytes) (Santos et al., 2011). Another study was 
conducted with 90% ethanolic extract of P. pyramidalis to 
assess the anti-inflammatory activity using Wistar rats 
with hemorrhagic cystitis. The groups treated with the 
extract (100 and 400 mg kg
-1
) showed a significant 
reduction of cyclophosphamide-induced MPO. 100 mg 
kg
-1
 concentration was significantly decreased in 
leukocyte   infiltration  in  the  urinary  bladder  and  basal  




concentration of MDA (Moraes et al., 2013). 
Santana et al. (2012) evaluated the anti-inflammatory 
activity of ethanolic extract of P. pyramidalis in acute 
pancreatitis model in rats. The authors investigated the 
levels of pancreatic enzymes in the blood, pancreas 
neutrophil infiltration, lipid peroxidation and abdominal 
hyperalgesia. The extract (400 mg kg
-1
) was able to 
reduce the levels of amylase and lipase in serum after 6 
or 24 h of induction; it also reduced MPO activity in 
pancreatic tissue, leading to a decrease in infiltration 
neutrophils and promoting anti-inflammatory effect. The 
extract also promoted protective effect against the 
lipoperoxidation caused by CBDO. MDA formation 
decreased after 6 h of pancreatitis induction, and was 
maintained for 24 h. In the hyperalgesia test was reported 
that the groups treated with the extract (100, 200 or 400 
mg kg
-1
) had a reduction in abdominal hyperalgesia after 
6 h of induction. This effect was maintained for 24 h for 
the highest concentration. These results demonstrate the 





The ethanolic extract of the bark of P. pyramidalis (100, 
200 and 400 mg kg
-1
) reduced significantly the contortion 
acetic acid-induced compared to the control group. 
Inhibition of nociceptive behavior occurred; it was 
induced by formalin at neurogenic and inflammatory 
phases. In the hot-plate reaction time, the extract (400 
mg kg
-1
) increased the pain latency time of mice exposed 
to the hot plate. The group treated with the extracts did 
not show any significant effects in the rotarod test 
(Santos et al., 2011). The possible mechanism of action 
of ethanol (90%) extract in the nociceptive behavior was 
investigated by Santos et al. (2013a). In the analysis of 
possible involvement of L-arginine–nitric oxide (NO), 
groups of mice were pre-treated intraperitoneally with 
nitric oxide precursor L-arginine (600 mg Kg
-1
) after 
receiving a nitric oxide synthase inhibitor L-NOARG (75 
mg Kg
-1
) or extract (30 mg Kg
-1
). The previous treatment 
with L-arginine reversed the antinociceptive effect of L-
NOARG and extract, suggesting the participation of L-
arginine/nitric oxide pathway in the antinociceptive 
activity of P. pyramidalis extract. We also observed 
antinociceptive effect on the glutamate induced 
nociception at 10, 30, and 100 mg Kg
-1
. The authors 






Ionizing radiation interaction with biological environment 
may have various effects such as death or mutation in 
cells, chromosomes and even DNA. Santos et al. (2013b) 
reported the effect of methanolic extracts of P. pyramidalis 





Biomphalaria glabrata embryos. The bark extract (250 
ppm) showed radioprotective activity in the groups 
irradiated with doses of 2.5 and 4.0 Gy, while the extract 
of the leaves at the same concentration showed activity 
in the groups irradiated with doses between 2.5 and 100 





Borges-dos-Santos et al. (2012) evaluated the potential 
benefits of the aqueous extract of P. pyramidalis on goats 
naturally infected with gastrointestinal nematodes. In vivo 
studies demonstrated a significant reduction in the count 
of eggs in the feces throughout the trial period; which, 
according to the authors, can be related to the direct 
activity of the extract reducing the fertility of female 
parasites. The extract also led to increased concentration 






The toxicity of plant species is one of the most important 
parameters in evaluating its timely use by the population. 
The bioassay with Artemia salina is commonly used to 
speculate toxicity of plant extracts. In the work of Luna et 
al. (2005), the ethanol extract of the stem bark (1000 
ppm) showed high toxicity, with 100% mortality forwarded 
to A. salina. Oliveira (2010), performing the same test, 
described the toxicity according to the polarity of the 
extracts, fractions with ethyl acetate and the more toxic 
methanol, followed by butanol. The hexane fraction was 






P. pyramidalis is a natural resource used extensively in 
the Brazilian semiarid region. This study has identified 
numerous compounds, largely with recognized action on 
the body. The species showed therapeutic potential; anti-
inflammatory, antioxidant and antimicrobial properties 
were the most pronounced and they validate its 
traditional use. All parts of the plant, including the stem, 
flower, root and leaf had pharmacological action and a 
wealth of compounds. But, it is necessary to identify and 
isolate the chemical constituents, and all those 
responsible for producing the therapeutic action, as well 
as conducting in vivo tests to determine the mechanisms 










resistant Staphylococcus aureus; MSSA, methicillin 
sensitive Staphylococcus aureus; VRSA, vancomycin-
resistant Staphylococcus aureus; ATCC, American Type 
Culture Collection; MIC, minimum inhibitory 
concentration; NorA, gene that encodes a membrane-
associated protein mediating active efflux of 
fluoroquinolones; DPPH, 2, 2-diphenyl-1-picrylhydrazyl; 
FIC, ferrous ion chelating; EDTA, 
ethylenediaminetetraacetic acid; IC50, amount of extract 
needed for 50% inhibition; BHT, butylated 
hydroxytoluene; L-NAME, Nw-nitro-L-arginine methyl 
ester Hydrochloride; PAG, DL-propargylglycine; MPO, 
myeloperoxidase; UMPO, units of MPO; CBDO, common 
bile duct obstruction; MDA, malondialdehyde; NO, nitric 
oxide; L-NOARG, Nω-nitro L-arginine. 
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